Daniel Moya Rull

Dr. Daniel Moya Rull is a researcher at the Institute for Bioengineering of Catalonia (IBEC), focusing on pluripotency and organ regeneration. His work integrates bioengineering, stem cell biology, and regenerative medicine to advance kidney organoid models and therapeutic strategies for genetic kidney diseases like polycystic kidney disease (PKD). His research also explores the impact of metabolic and genetic factors in cancer, particularly gastric and colorectal cancers, with an emphasis on precision medicine and drug sensitivity. Recent studies include developing kidney organoid platforms to study SARS-CoV-2 infection dynamics in diabetic conditions. He collaborates on extracellular vesicle-based therapies for kidney protection and has contributed to understanding the role of mTOR signaling in metabolic and transplant-related pathologies.

Research Interests:

• Pluripotent stem cell engineering for organ regeneration
• Kidney organoid development and disease modeling
• Therapeutic targeting of ciliary-autophagy pathways in PKD
• Metabolic and genetic drivers of gastrointestinal cancers
• Extracellular vesicle applications in regenerative and translational medicine
• Impact of immunosuppressive drugs on cancer progression

Publications highlight his contributions to both fundamental and translational research, bridging bioengineering innovations with clinical challenges in nephrology and oncology. His work emphasizes preclinical models (e.g., patient-derived xenografts) and innovative biomaterials for tissue engineering.